Toggle navigation
ABOUT US
Overview
Leadership
Governance
Board
Our purpose
Global footprint
Our global reach
Partners
Press releases
News
Our science
Drug optimization
Lauriad
®
technology
Overview
How it works
Scientific publications
Lauriad
®
applications
OUR MEDICINES
PIPELINE
Commercialized medicines
LAURIAD
®
ACICLOVIR
LAURIAD
®
MICONAZOLE
PARTNER WITH US
Commercial & Industrial partners
Academic & Research collaborations
Careers
Working at Vectans Pharma
Join us
CONTACT
Substipharm and Athena Pharmaceutiques Acquire Controlling Interest in Vectans Pharma to Drive Global Growth and Innovation
Read the press release
Last news
Vectans Pharma is excited to announce its collaboration with Athena and Subtipharm
Substipharm and Athena Pharmaceutiques Acquire Controlling Interest in Vectans Pharma to Drive Global Growth and Innovation
A common goal, to improve the lives of patients
OTC switch approval in Sweden for Virono®50mg
A brighter horizon for Oropharyngeal Candidiasis patients in Argentina
230 Bureaux de la colline
92213 Saint-Cloud
France
contact@vectans.com
FOLLOW US
Copyright © VECTANS PHARMA
Legal notices and privacy policy
